J. Craig Venter Institute Overview
- Year Founded
-
1992
- Status
-
Private
- Employees
-
120
- Latest Deal Type
-
Grant
- Financing Rounds
-
1
- Investments
-
1
J. Craig Venter Institute General Information
Description
Operator of genomics and bioinformatics research institutes intended to advance human health and the environment based in La Jolla, California. The company conducts various researches on genomics medicines, infectious diseases, mammalian genomics, microbial & environmental genomics, and synthetic biology.
Contact Information
Website
www.jcvi.orgCorporate Office
- 4120 Capricorn Lane
- La Jolla, CA 92037
- United States
Corporate Office
- 4120 Capricorn Lane
- La Jolla, CA 92037
- United States
J. Craig Venter Institute Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
J. Craig Venter Institute Comparisons
Industry
Financing
Details
J. Craig Venter Institute Competitors (2)
One of J. Craig Venter Institute’s 2 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Volastra | Venture Capital-Backed | New York, NY |
J. Craig Venter Institute Patents
J. Craig Venter Institute Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025250851-A1 | Trivalent pan-sarbecovirus mucosal vaccine constructs and methods of making and using same | Pending | 29-May-2024 | ||
| WO-2024226178-A2 | Single copy human artificial chromosome (hac) vectors and methods of preparation and use thereof | Inactive | 08-Mar-2023 | ||
| WO-2024226178-A3 | Single copy human artificial chromosome (hac) vectors and methods of preparation and use thereof | Inactive | 08-Mar-2023 | ||
| US-20250349433-A1 | Methods and systems for determining dental caries | Pending | 11-May-2022 | ||
| WO-2023220080-A1 | Methods and systems for determining dental caries | Inactive | 11-May-2022 | G16H50/30 |
J. Craig Venter Institute Signals
J. Craig Venter Institute Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
J. Craig Venter Institute Investments (1)
J. Craig Venter Institute’s most recent deal was a University Spin-Out with Diploid Genomics. The deal was made on 01-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Diploid Genomics | 01-Jan-2026 | University Spin-Out | Discovery Tools (Healthcare) |
J. Craig Venter Institute FAQs
-
When was J. Craig Venter Institute founded?
J. Craig Venter Institute was founded in 1992.
-
Where is J. Craig Venter Institute headquartered?
J. Craig Venter Institute is headquartered in La Jolla, CA.
-
What is the size of J. Craig Venter Institute?
J. Craig Venter Institute has 120 total employees.
-
What industry is J. Craig Venter Institute in?
J. Craig Venter Institute’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is J. Craig Venter Institute a private or public company?
J. Craig Venter Institute is a Private company.
-
What is J. Craig Venter Institute’s current revenue?
The current revenue for J. Craig Venter Institute is .
-
Who are J. Craig Venter Institute’s investors?
National Institute Of Allergy and Infectious Diseases, The Roddenberry Foundation, and US National Science Foundation have invested in J. Craig Venter Institute.
-
Who are J. Craig Venter Institute’s competitors?
Genentech and Volastra are competitors of J. Craig Venter Institute.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process